Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

A combination of transarterial chemoembolization (TACE) with lenvatinib (Lenvima) and pembrolizumab (Keytruda) significantly improved progression-free survival (PFS) compared with TACE alone in ...

In patients with recurrent small hepatocellular carcinoma (HCC), stereotactic body radiotherapy (SBRT) demonstrated superior local progression-free survival (PFS) and tumor control at 3 years ...

But after a couple of years of work, xMEMS has arrived at the next generation — ultrasound through a solid-state speaker. This tiny, 1mm-thin speaker is called Cypress, and after listening to it ...

Correlations seen with fecal calprotectin, endoscopic disease activity, but not clinical disease activity. HealthDay News — Intestinal ultrasound (IU) can be considered a screening tool for pediatric ...

Current surveillance regimes of α-fetoprotein and ultrasound may be augmented by novel biomarkers of HCC discovered through new technologies, such as proteomics and metabonomics. Novel ablative ...

Objective: To determine the diagnostic value of ultrasound, multi-phase enhanced computed tomography, and magnetic resonance imaging of small hepatocellular carcinoma. Methods: Experimental studies on ...

The device delivers ultrasound energy to the patient’s pancreas and generates localized heat of up to 100 degrees Celsius that destroys cancer cells in the organ. Other types of ultrasound waves ...

A global trial has shown that a combination of lenvatinib, pembrolizumab, and transarterial chemoembolization (TACE) significantly improves progression-free survival in patients with intermediate ...

This case highlights the rarity of isolated pelvic metastasis in HCC patients and underscores the importance of AFP in postoperative monitoring. The combination of PET-CT imaging and pathological ...